https://www.selleckchem.com/pr....oducts/cytosporone-b
Portopulmonary hypertension (POPH) is a pulmonary vascular disease associated with significant morbidity and mortality in those with liver disease, conferring a higher mortality in patients awaiting liver transplantation (LT). Although not a transplant indication, patients with POPH can experience significant clinical improvement following LT, and those maintaining a mean pulmonary artery pressure (MPAP) less then 35mm Hg and a pulmonary vascular resistance (PVR) less then 5 Woods units (WU) are granted additional listing points t
Like
Comment
Share
